SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-038506
Filing Date
2024-02-16
Accepted
2024-02-16 16:21:07
Documents
14
Period of Report
2024-02-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d773011d8k.htm   iXBRL 8-K 41525
  Complete submission text file 0001193125-24-038506.txt   169278

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cgon-20240215.xsd EX-101.SCH 2877
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgon-20240215_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgon-20240215_pre.xml EX-101.PRE 11725
15 EXTRACTED XBRL INSTANCE DOCUMENT d773011d8k_htm.xml XML 3768
Mailing Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618 (949) 419-6203
CG Oncology, Inc. (Filer) CIK: 0001991792 (see all company filings)

IRS No.: 371611499 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41925 | Film No.: 24648680
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)